Mirati Therapeutics, Inc.
MRTX
NASDAQ Global Select58.70
USD
-0.10
- -
Total Valuation
Mirati Therapeutics, Inc. carries a market capitalization of 4.12B, placing it among publicly traded companies globally.
| Market Cap | 4.12B |
| Enterprise Value | N/A |
Stock Price Statistics
Mirati Therapeutics, Inc.'s stock has gained approximately 29.43771% over the past 52 weeks. The 50-day moving average sits at 57.69, while the 200-day moving average is 45.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | 29.43771% |
| 50-Day Moving Average | 57.69 |
| 200-Day Moving Average | 45.48 |
| Average Volume (20 Days) | N/A |
Stock Splits
Mirati Therapeutics, Inc.'s most recent stock split took place on July 3, 2013 with a 50:1 split ratio.
| Last Split Date | 7/3/2013 |
| Split Ratio | 50:1 |